Emerging BioTalk
  • Home
  • About Us
  • Contact
  • Search
  • Menu

Mind the Gaps: A Perspective from the World of Academic Spinouts

November 11, 2020/in Uncategorized /by Michele Washko

Depending upon your perspective, “emerging” biotech could mean any number of things, ranging all the way from the recent spinout of an academic lab to a publicly held company developing a therapeutic that has not yet reached the marketplace. My company, Respana Therapeutics (a finalist in

MilliporeSigma’s
Merck’s
North America Advance Biotech Grant Program) sits at the front end of that continuum. This is a thrilling, and sometimes anxiety-inducing, place to be.

Thrilling you get, right? Cutting edge science, the potential for a big payout, etc. But anxiety-inducing? There are numerous reasons for this. Some of the key ones fall under the heading of gaps: technical gaps, gaps in funding, and gaps in expertise.

Technical gaps are familiar to anyone working in a biopharma firm, large or small. Examples include success at the bench that proves elusive at scale, manufacturing that’s projected to be cost-prohibitive, or failure of a clinical trial in Phase I, II or (ouch) III.

Potential gaps in funding are also familiar to most, regardless of company size. As of this writing, in early November, those working in well-established biopharma companies are probably in the middle of the budget review process. This annual vetting of development programs invariably necessitates tradeoffs.

But if you’ve never worked in venture capital or a startup you may not have experienced the “Valley of Death.” This refers to the point in a young company’s life cycle wherein the firm is ready to move further and faster than government grant funding, sweat equity and so-called “friends and family” money can take it buts lacks sufficient preclinical data to attract private investment.

Gaps in expertise can also be a challenge. This is in no way an attempt to undersell the work of academic labs! Respana Therapeutics and countless other firms contributing to global pipeline of novel therapeutics wouldn’t exist without the vision of so many working within academic and not-for-profit research institutions. A shout goes out here to Dr. Zissis Chroneos, Respana’s scientific co-founder, who has dedicated decades to the study of respiratory illness and whose insights into surfactant protein A receptor SPR-210 stimulated development of Respana’s therapeutic mAb. Invariably, however, the skills that lead to success in an early stage research environment will require complementary expertise in translational science and commercialization. (See a related post to this forum from Barri Blauvelt.)

Addressing these gaps is where programs like

MilliporeSigma’s
Merck’s
North America Advance Biotech Grant Program can make a real difference. Resources like technical expertise, advanced equipment and cash equivalents for laboratory essentials made available during the critical early stages can mean the difference between shelving a promising therapeutic candidate and advancing it into the clinic.

Despite the challenges of working within this stage of the company life cycle, many of us who work in early stage life sciences firms wouldn’t want to do anything else. We do this work because of a passion for the science, the drive to improve healthcare, or both. If you’ve read this far, you probably feel the same way – so, let’s get back to work. And if you happen to be part of, or are contemplating starting, a life sciences startup in Pennsylvania, here are some additional, regionally based resources that Respana Therapeutics has found helpful:

https://ic3401.org/

www.LSGPA.com

www.BioAdvance.com

https://sciencecenter.org/

https://cnp.benfranklin.org/

 

 

  • Author
  • Recent Posts
Michele Washko
COO at Respana Therapeutics
Michele Washko is COO of Respana Therapeutics, Founder of Life Science Innovations Consulting, and instructor of Health Economics at Harrisburg University of Science and technology.

https://www.linkedin.com/in/michelewashko/
Latest posts by Michele Washko (see all)
  • Mind the Gaps: A Perspective from the World of Academic Spinouts - November 11, 2020
+4
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share by Mail
http://emergingbiotalk.com/wp-content/uploads/2020/10/GettyImages-470620881-scaled.jpg 1707 2560 Michele Washko http://emergingbiotalk.com/wp-content/uploads/2020/05/emergingbiotalk-header.png Michele Washko2020-11-11 19:33:382022-10-19 08:54:23Mind the Gaps: A Perspective from the World of Academic Spinouts

Biotech Resource Hub >>

  • SUBSCRIBE TO OUR BLOG
  • SUBMIT YOUR BLOG POST

Latest News

  • 5 Minutes could win you $275,000 in products and services!January 30, 2023 - 8:50 am
  • Upcoming Seminar in India: Fast track through regulatory challengesFebruary 6, 2023 - 1:10 pm
  • Enter for a chance to win $275,000 in products and services!January 9, 2023 - 11:14 am

Categories

  • Bioprocessing
  • Biosafety Testing
  • End-to-End Solutions
  • Frontpage Article
  • Gene Therapy
  • Investigator's Brochure
  • News
  • Uncategorized
  • Vaccines
  • Viral Vectors
  • Webinar

Archives

  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • May 2020
  • April 2020
  • SUBSCRIBE TO OUR BLOG
  • SUBMIT YOUR BLOG POST

Latest News

  • 5 Minutes could win you $275,000 in products and services!January 30, 2023 - 8:50 am
  • Upcoming Seminar in India: Fast track through regulatory challengesFebruary 6, 2023 - 1:10 pm
  • Enter for a chance to win $275,000 in products and services!January 9, 2023 - 11:14 am

Categories

  • Bioprocessing
  • Biosafety Testing
  • End-to-End Solutions
  • Frontpage Article
  • Gene Therapy
  • Investigator's Brochure
  • News
  • Uncategorized
  • Vaccines
  • Viral Vectors
  • Webinar

Archives

  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • May 2020
  • April 2020

Tags

applications bioprocessing biotech blazar Congratulations Content education Europe FDA Format gene therapy grant grants Investigator's Brochure molecule new NGS Pharmaceuticals program services symposia tags things Tone VAR2 viral assurance viral clearance virus virus detection winner

Business Hours

Our support Hotline is available 24 Hours a day: (555) 343 456 7891

  • Monday-Friday: 9am to 5pm
  • Saturday: 10am to 2pm
  • Sunday: Closed

Latest News

  • 5 Minutes could win you $275,000 in products and services!January 30, 2023 - 8:50 am
  • Upcoming Seminar in India: Fast track through regulatory challengesFebruary 6, 2023 - 1:10 pm
  • Enter for a chance to win $275,000 in products and services!January 9, 2023 - 11:14 am
  • The Future of BiopharmaDecember 6, 2022 - 4:39 am
  • Last chance: 3rd Annual Startup Symposium – Day 3November 10, 2022 - 5:39 am
  • The Lack of Funding for Women Entrepreneurs Doesn’t Stop Them from Launching – But We Still Have a Long Way to Go – And We Can Help Each Other. Assurea is ROOTING FOR YOU!October 21, 2022 - 8:27 am

Categories

  • Bioprocessing
  • Biosafety Testing
  • End-to-End Solutions
  • Frontpage Article
  • Gene Therapy
  • Investigator's Brochure
  • News
  • Uncategorized
  • Vaccines
  • Viral Vectors
  • Webinar
  • Author
  • Recent Posts
Michele Washko
COO at Respana Therapeutics
Michele Washko is COO of Respana Therapeutics, Founder of Life Science Innovations Consulting, and instructor of Health Economics at Harrisburg University of Science and technology.

https://www.linkedin.com/in/michelewashko/
Latest posts by Michele Washko (see all)
  • Mind the Gaps: A Perspective from the World of Academic Spinouts - November 11, 2020
+4
© 2020 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. | Privacy Policy | Cookie Settings
Virtual ADC & Bioconjugation Symposium – December 2-3, 2020 Investment in Internal Process Development and Manufacturing Enables Rapid Product...
Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. We use cookies in our website to give you the most relevant experience. By clicking or navigating the site, you are accepting the use of all our cookies according to our Cookie Policy / Privacy Statement. You are free to decide in the Cookie Settings which categories you would like to allow. Please note that depending on what you select, the full functionality of the website may no longer be available. You may review and change your choices at any time. Further information can be found in our Privacy Policy

Accept All CookiesCookie Settings

Cookie and Privacy Settings



Cookie Preferences

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about how we use and share your data, please follow this link.
Privacy Statement

Necessary

Always Active
These cookies are necessary for the website to operate. Our website cannot function without these cookies and they can only be disabled by changing your browser preferences.

Functional

These cookies enable the provision of advanced functionalities and are used for personalization. The cookies are set in particular in response to your actions and depend on your specific service requests (e.g., pop-up notification choices).Changes will take effect once you reload the page.

Targeting

These cookies may be set to learn more about your interests and show you relevant ads on other websites. These cookies work by uniquely identifying your browser and device. By integrating these cookies, we aim to learn more about your interests and your surfing behavior and to be able to place our advertising in a targeted manner.

Confirm My ChoicesAllow AllDisable All

loading

Please wait while you are redirected to the right page...

Please share your location to continue.

Check our help guide for more info.

share your location